Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
BIO-key International, Inc. Announces Pricing of $1.8 Million Offering of Common Stock and Warrants
-
Maxim Group Starts BJ's Restaurants (BJRI) at Buy
-
Saratoga Investment Corp. Prices Public Offering of $35 Million 6.25% Notes Due 2025
-
Saratoga Investment Corp. Prices Public Offering of $35 Million 6.25% Notes Due 2025
-
Saratoga Investment Corp. Announces Offering of Notes Due 2025 and BBB Investment Grade Rating from Egan-Jones Ratings Company.
-
Saratoga Investment Corp. Announces Offering of Notes Due 2025 and BBB Investment Grade Rating from Egan-Jones Ratings Company.
-
Bionano Genomics Announces Pricing of Initial Public Offering
-
Tenzing Acquisition Corp. (TZAC) Prices 5.5M Unit IPO at $10/Unit
-
Tenzing Acquisition Corp. Announces Pricing of Upsized $55,000,000 Initial Public Offering
-
Adamis Pharmaceuticals (ADMP) Defended at Maxim
-
Maxim Group Starts Dare Bioscience (DARE) at Buy
-
Illness at Ohio Chipotle caused by food-borne bacteria: local officials
-
New Age Beverages Corp (NBEV) PT Lowered to $3 at Maxim Group
-
NetApp (NTAP) PT Raised to $91 at Maxim Group
-
Maxim Group LLC Enhances Executive Leadership
-
BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services
-
BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services
-
Applied DNA Sciences (APDN) PT Lowered to $3 at Maxim Group
-
Maxim Group Downgrades Cytori Therapeutics, Inc. (CYTX) to Hold
-
China YCT International Group Reports Financial Results for the Fiscal Quarter Ended June 30, 2018
-
Tecogen (TGEN) PT Lowered to $5 at Maxim Group
-
Restoration Robotics (HAIR) PT Lowered to $6 at Maxim Group
-
Virtra (VTSI) PT Raised to $12 at Maxim Group
-
Aridis Pharmaceuticals Inc. (ARDS) Prices 2M Share IPO at $13/Sh
-
Aridis Pharmaceuticals Announces Pricing of Initial Public Offering
-
Zoe's Kitchen (ZOES) PT Lowered to $10 at Maxim Group
-
Matinas BioPharma Holdings Inc. (MTNB) PT Lowered to $2 at Maxim Group
-
Ecoark Announces $4.75 Million Registered Direct Offering
-
Omeros Corp. (OMER) PT Raised to $32 at Maxim Group
-
I-ON Communications Corp. Announces the Appointment of Four New Independent Board Members and Opening of New U.S. Headquarters
-
BioLife Solutions (BLFS) PT Raised to $26 at Maxim Group
-
BeiGene, Ltd. (BGNE) PT Lowered to $215 at Maxim Group
-
SenesTech Announces Approximately $6.1 Million in Expected Gross Proceeds from Rights Offering
-
Biocept Announces $11.6 Million in Expected Gross Proceeds from Recently Expired Rights Offering
-
Coherus Biosciences (CHRS) PT Raised to $25 at Maxim Group; Sees Transformative Q4
-
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
-
ContraVir Pharma (CTRV) Announces Update to Business Activities
-
ContraVir Pharmaceuticals Provides an Update to Corporate Objectives
-
Aridis Pharmaceuticals Launches Proposed Initial Public Offering
-
New York Mortgage Trust (NYMT) PT Raised to $6.75 at Maxim Group
-
Maxim Group Downgrades Immune Pharmaceuticals (IMNP) to Hold CIting Financing Concerns
-
SenesTech, Inc. Announces Updated Pricing Terms of Rights Offering and Reminds Subscription Holders of August 8, 2018 Expiration Date
-
Tableau Software (DATA) PT Raised to $107 at Maxim Group
-
Maxim Group Downgrades Habit Restaurants (HABT) to Hold Citing Valuation
-
CytoSorbents (CTSO) PT Raised to $18 at Maxim Group
-
Maxim Group Starts Entera Bio (ENTX) at Buy
-
Adamis Pharmaceuticals (ADMP) Prices 11.67M Share Common Offering at $3/Sh
-
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Maxim Group Starts Capstone Turbine (CPST) at Buy
-
Chipotle slumps 9 percent after Ohio outlet linked to food poisoning complaints

